Who are Hyperpolarized xenon's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): 129Xe.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hyperpolarized-xenon.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

Hyperpolarized xenon — Competitive Intelligence Brief

Hyperpolarized xenon (Hyperpolarized xenon) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hyperpolarized contrast agent. Area: Respiratory/Pulmonary Imaging.

marketed Hyperpolarized contrast agent Xenon-129 nuclear spins Respiratory/Pulmonary Imaging Small molecule Live · refreshed every 30 min

Target snapshot

Hyperpolarized xenon (Hyperpolarized xenon) — Oxford University Hospitals NHS Trust. Hyperpolarized xenon is inhaled as a contrast agent that enhances magnetic resonance imaging (MRI) by providing increased signal in lung tissue due to its nuclear spin polarization.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Hyperpolarized xenon TARGET	Hyperpolarized xenon	Oxford University Hospitals NHS Trust	marketed	Hyperpolarized contrast agent	Xenon-129 nuclear spins
129Xe	129Xe	Children's Hospital Medical Center, Cincinnati	marketed	Hyperpolarized contrast agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hyperpolarized contrast agent class)

Children's Hospital Medical Center, Cincinnati · 1 drug in this class
Oxford University Hospitals NHS Trust · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hyperpolarized xenon — Competitive Intelligence Brief. https://druglandscape.com/ci/hyperpolarized-xenon. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab